Biomarker-Based Assessment: The identification of specific mitochondrial-associated oxidative stress biomarkers, such as Humanin, MOTS-c, and p66shc, provides a new avenue for assessing depression severity. The gene discussed is MT-RNR1; the disease is depressive disorder.